1 recruiting, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Terminated 1 |
Follow Recurrent Cutaneous Melanoma: new trials by email Literature Review of Recurrent Cutaneous Melanoma trials Research Report on Recurrent Cutaneous Melanoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer Neoantigen Peptide Vaccine, Nivolumab, Poly ICLC - Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 | Phase 1 | Recruiting | Fred Hutchinson Cancer Center | 28 | 2022-06-09 | 2026-07-22 |
| Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors Cord Blood-derived Expanded Allogeneic Natural Killer Cells, Cyclophosphamide, Etoposide - Recurrent Cutaneous Melanoma, Recurrent Lip and Oral Cavity Carcinoma | Phase 1 | Terminated | M.D. Anderson Cancer Center | 12 | 2018-08-31 | 2026-03-20 |
Melanoma (2) · Bone Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Endocrine Gland Neoplasms (1) · Lung Neoplasms (1) · Mesothelioma, Malignant (1) · Mouth Neoplasms (1) · Neoplasm Metastasis (1) · Pharyngeal Neoplasms (1) · Sarcoma (1) · Skin Neoplasms (1) · Thyroid Neoplasms (1) · Urologic Neoplasms (1)
Lung Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Nerve Tissue (2) · Neuroectodermal Tumors (2) · Neuroendocrine Tumors (2) · Nevi and Melanomas (2) · Respiratory Tract Diseases (2) · Respiratory Tract Neoplasms (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Thoracic Neoplasms (2) · Adenoma (1)
Biopsy (1) · Cyclophosphamide (1) · Etoposide (1) · Magnetic Resonance Spectroscopy (1) · Nivolumab (1) · poly ICLC (1) · ruxolitinib (1)
Fred Hutchinson Cancer Center (1) · M.D. Anderson Cancer Center (1)
United States (2)
Demetrios Petropoulos (1) · Joshua Veatch (1)
P30CA016672 (1)